These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9406964)

  • 21. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of p-chloroamphetamine on brain serotonin neurons.
    Fuller RW
    Neurochem Res; 1992 May; 17(5):449-56. PubMed ID: 1528354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract]   [Full Text] [Related]  

  • 25. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 26. Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse.
    Colado MI; Ormazabal MJ; Goicoechea C; Lopez F; Alfaro MJ; Martin MI
    Eur J Pharmacol; 1994 Feb; 252(3):291-7. PubMed ID: 7512926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute melatonin and para-chloroamphetamine interactions on pineal, brain and serum serotonin levels as well as stress hormone levels.
    Manzana EJ; Chen WJ; Champney TH
    Brain Res; 2001 Aug; 909(1-2):127-37. PubMed ID: 11478929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function?
    Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1974; 10():83-91. PubMed ID: 4367772
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system.
    Morrow BA; Roth RH
    Synapse; 1996 Jul; 23(3):174-81. PubMed ID: 8807745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin and the control of ventilation in awake rats.
    Olson EB; Dempsey JA; McCrimmon DR
    J Clin Invest; 1979 Aug; 64(2):689-93. PubMed ID: 156738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
    Steed E; Jones CA; McCreary AC
    Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic involvement in pharmacological action of the anxiolytic-sedatives thalidomide and supidimide.
    Youdim MB; Ashkenazi R
    Eur J Pharmacol; 1985 Dec; 119(1-2):39-46. PubMed ID: 2867921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of methysergide, a blocker of serotonin receptors, on plasma prolactin levels in lactating and ovariectomized rats.
    Gallo RV; Rabii J; Moberg GP
    Endocrinology; 1975 Nov; 97(5):1096-105. PubMed ID: 126860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raphe origin of serotonin-containing neurons within choroid plexus of the rat.
    Moskowitz MA; Liebmann JE; Reinhard JF; Schlosberg A
    Brain Res; 1979 Jun; 169(3):590-4. PubMed ID: 156057
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of an atypical barbiturate (valofan) on spontaneous and stimulated locomotor activity and on brain serotonin metabolism in mice.
    Traversa U; Puppini P; Florio C; Vertua R
    Farmaco Sci; 1987 Oct; 42(10):755-66. PubMed ID: 2449358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.